<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
HAE
Haemonetics
$
()


  • Haemonetics receives FDA clearance for TEG 6s Global Hemostasis-HN cartridge

    4/4/2024 - 06:32am
  • Haemonetic sees Attune Medical acquisition adding $30M-$35M in revenue in FY25

    4/1/2024 - 08:12am
  • Haemonetics management to meet with Oppenheimer

    3/19/2024 - 04:55am
  • Haemonetics management to meet with Oppenheimer

    3/13/2024 - 16:10pm
  • Haemonetics to acquire Attune Medical for $160M upfront, sees accretion

    3/5/2024 - 06:02am
  • Haemonetics raises FY24 adjusted EPS view to $3.90-$4.00 from $3.75-$3.95

    2/8/2024 - 06:09am
  • Haemonetics reports Q3 adjusted EPS $1.04, consensus 94c

    2/8/2024 - 06:04am
  • Citi entering 2024 'cautiously optimistic' on U.S. MedTech companies

    12/11/2023 - 11:19am
  • Needham medtech analysts hold analyst/industry conference call

    11/29/2023 - 11:25am
  • Needham medtech analysts hold analyst/industry conference call

    11/29/2023 - 04:55am
  • Needham medtech analysts hold analyst/industry conference call

    11/20/2023 - 16:22pm
  • Haemonetics management to meet with Barrington

    11/16/2023 - 04:55am
  • Haemonetics management to meet with Barrington

    11/9/2023 - 16:27pm
  • Haemonetics price target lowered to $105 from $114 at Barrington

    11/3/2023 - 09:08am
  • Haemonetics raises FY24 adjusted EPS view to $3.75-$3.95 from $3.60-$3.90

    11/2/2023 - 06:45am
dynamic_feed Breaking News